Alivus Life Sciences Ltd.

Financial

	Alivus Life Sciences	Neuland Laboratories	IOL Chem & Pharma
Operational Metrics
Pharmaceutical Sector
US DMF Filings	561.0 .	72.0 .	n/a
Unclassified
Number of ANDA's Filed	n/a	n/a	n/a
R&D as a % of Total Sales	3.4 %	4.15 %	1.01 %
Financials
5 yr Average ROE	37.41 %	14.95 %	8.9 %
5yr average Equity Multiplier	2.33	1.56	1.42
5yr Average Asset Turnover Ratio	0.76	0.74	0.99
5yr Avg Net Profit Margin	20.19 %	13.18 %	6.28 %
Price to Book	4.36	10.97	1.74
P/E	24.77	95.0	29.13
5yr Avg Cash Conversion Cycle	76.63 Days	38.21 Days	37.81 Days
Inventory Days	93.94 Days	87.5 Days	65.55 Days
Days Receivable	125.3 Days	85.17 Days	86.45 Days
Days Payable	114.87 Days	118.14 Days	100.1 Days
5yr Average Interest Coverage Ratio	320.13	20.78	15.8
5yr Avg ROCE	51.63 %	17.63 %	12.63 %
5yr Avg Operating Profit Margin	30.06 %	21.01 %	10.64 %
5 yr average Debt to Equity	0.0	0.15	0.04
5yr CAGR Net Profit	8.5 %	26.4 %	-9.63 %
5yr Average Return on Assets	15.32 %	9.87 %	6.27 %
Shareholdings
Promoter Holding	74.94 %	32.68 %	52.62 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-7.91 %	-3.54 %	8.93 %
Change in Mutual Fund Holding (3 Yrs)	3.35 %	6.87 %	0.0

Business

	Alivus Life Sciences	Neuland Laboratories	IOL Chem & Pharma
Product Wise Break-Up	Product Wise Break-Up Generic API 24.89 CDMO 1.82 API`s 0 Generic Drug Substances(GDS) 0 Custom Manufacturing Solutions(CMS) 0 API 0 Chemicals 0 Ethyl Acetate 0 Ibuprofen 0 Pantaprazole 0 Clopidogrel 0 Metformin 0 Others 73.29	Product Wise Break-Up Metformin 0 Ibuprofen 0 Formulations 59.0 API`s 0 Chemicals 0 Ethyl Acetate 0 Custom Manufacturing Solutions(CMS) 34.0 API 0 Pantaprazole 0 Clopidogrel 0 CDMO 0 Generic API 0 Others 7.0	Product Wise Break-Up Metformin 0 Ibuprofen 37.0 Generic Drug Substances(GDS) 0 API`s 0 Chemicals 43.0 Ethyl Acetate 0 Custom Manufacturing Solutions(CMS) 0 API 20.0 Pantaprazole 0 Clopidogrel 0 CDMO 0 Generic API 0
Location Wise Break-Up	Location Wise Break-Up India 51.09 Rest of the World 0 USA 0 Europe 0 Others 48.91	Location Wise Break-Up India 30.39 USA 29.35 Rest of the World 10.4 Europe 29.86	Location Wise Break-Up India 73.0 USA 0 Rest of the World 27.0 Europe 0
Customer Segment	Customer Segment Regulated Markets 86.0 Emerging Markets 14.0	-	-
Therapeutic Area Break-Up	Therapeutic Area Break-Up CVS 42.0 CNS 14.0 Pain Management 4.0 Diabetes 4.0 Anticonvulsant 0 Antidepressant 0 Antibacterial 0 Others 36.0	Therapeutic Area Break-Up CNS 0 Antidepressant 11.8 Pain Management 0 Anti-bacterial 19.72 CVS 0 Anticonvulsant 10.46 Diabetes 0 Others 58.02	-
Acute vs Chronic	Acute vs Chronic Chronic 64.0 Acute 36.0	-	-
Customer Wise Break-Up	Customer Wise Break-Up External 66.4 GPL 33.6	-	-
Asset Break-Up - Geography Wise	Asset Break-Up - Geography Wise Others 100	-	-

Alivus Life Sciences Ltd.

SIGN UP FOR FREE